Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001723643-25-000015·Neuphoria Therapeutics Inc.
Schedule 13G ownership disclosure
NEUPHORIA THERAPEUTICS INC
Common Stock, $0.00001 par value per share · CUSIP: 64136E102
Event date: 2025-10-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Shay Capital LLC
Shares: 171,629.00 · Class: 7.3%
- Shay Capital Holdings LLC
Shares: 171,629.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001723643-25-000015
- Form type
- SCHEDULE 13G
- Filer
- Neuphoria Therapeutics Inc.
- CIK
- CIK 1191070
- Filed
- Oct 31, 2025
- Reporting period
- Oct 24, 2025
- Description
- Schedule 13G beneficial ownership